Related references
Note: Only part of the references are listed.Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2020)
Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss
Rosario Gulino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Clobetasol Modulates Adult Neural Stem Cell Growth via Canonical Hedgehog Pathway Activation
Nunzio Vicario et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872
Evanthia Galanis et al.
CANCER (2019)
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor
Anna Lucia Fallacara et al.
CANCERS (2019)
Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line
Francesco P. Cammarata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Effects of mir-128a on the invasion and proliferation of glioma U251 cells
Guozhang Hu et al.
ONCOLOGY LETTERS (2019)
Evaluation of RGD functionalization in hybrid hydrogels as 3D neural stem cell culture systems
Emanuele Mauri et al.
BIOMATERIALS SCIENCE (2018)
Imaging of brain oxygenation with magnetic resonance imaging: A validation with positron emission tomography in the healthy and tumoural brain
Samuel Valable et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
Stefanie Keller et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
In Vivo Relationship Between Hypoxia and Angiogenesis in Human Glioblastoma: A Multimodal Imaging Study
Keven Ferreira da Ponte et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and invasion
Alison Roos et al.
FRONTIERS IN ONCOLOGY (2017)
EGFRvIII/integrin β3 interaction in hypoxic and vitronectin-enriching microenvironment promote GBM progression and metastasis
Zhaoyu Liu et al.
ONCOTARGET (2016)
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI
Elizabeth R. Gerstner et al.
CLINICAL CANCER RESEARCH (2016)
Suppression of SRC Signaling Is Effective in Reducing Synergy between Glioblastoma and Stromal Cells
Alessia Calgani et al.
MOLECULAR CANCER THERAPEUTICS (2016)
The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In Vivo
Keun-Yong Eom et al.
CANCER RESEARCH AND TREATMENT (2016)
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline
Alvin R. Cabrera et al.
PRACTICAL RADIATION ONCOLOGY (2016)
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Vicki Plaks et al.
CELL STEM CELL (2015)
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
Andrew B. Lassman et al.
NEURO-ONCOLOGY (2015)
Cellular and Molecular Mechanisms Underlying Oxygen-Dependent Radiosensitivity
Chao Liu et al.
RADIATION RESEARCH (2015)
Combining X-ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo against Neuroblastoma
Cristina Tintori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe
Elodie A. Peres et al.
ONCOTARGET (2015)
A mechanistic investigation of the oxygen fixation hypothesis and oxygen enhancement ratio
David Robert Grimes et al.
BIOMEDICAL PHYSICS & ENGINEERING EXPRESS (2015)
Randomized, placebo-controlled, phase II study of dasatinib with standard chemo-radiotherapy for newly diagnosed glioblastoma (GBM), NCCTG N0877 (Alliance)
Nadia N. Laack et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Biologically Driven Synthesis of Pyrazolo[3,4-d]pyrimidines As Protein Kinase Inhibitors: An Old Scaffold As a New Tool for Medicinal Chemistry and Chemical Biology Studies
Silvia Schenone et al.
CHEMICAL REVIEWS (2014)
Can the two mechanisms of tumor cell killing by radiation be exploited for therapeutic gain?
J. D. Chapman
JOURNAL OF RADIATION RESEARCH (2014)
Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma
David A. Reardon et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents
Sagar Agarwal et al.
MOLECULAR CANCER THERAPEUTICS (2012)
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma
Enrico Franceschi et al.
NEURO-ONCOLOGY (2012)
HIF-1 and c-Src Mediate Increased Glucose Uptake Induced by Endothelin-1 and Connexin43 in Astrocytes
Jose Carlos Valle-Casuso et al.
PLOS ONE (2012)
Basics of particle therapy II: relative biological effectiveness
Jinhyun Choi et al.
RADIATION ONCOLOGY JOURNAL (2012)
The Three-Layer Concentric Model of Glioblastoma: Cancer Stem Cells, Microenvironmental Regulation, and Therapeutic Implications
Luca Persano et al.
THESCIENTIFICWORLDJOURNAL (2011)
Targeting SRC in glioblastoma tumors and brain metastases Rationale and preclinical studies
Manmeet S. Ahluwalia et al.
CANCER LETTERS (2010)
αvβ3/αvβ5 Integrins-FAK-RhoB: A Novel Pathway for Hypoxia Regulation in Glioblastoma
Nicolas Skuli et al.
CANCER RESEARCH (2009)
Linear quadratic and tumour control probability modelling in external beam radiotherapy
S. F. C. O'Rourke et al.
JOURNAL OF MATHEMATICAL BIOLOGY (2009)
Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways
Chang-Min Park et al.
CANCER RESEARCH (2006)
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation
F Carraro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Share Paper
